Clinical Trial Funding Agreement Sample Contracts

CLINICAL TRIAL FUNDING AGREEMENT
Clinical Trial Funding Agreement • May 16th, 2011 • Nile Therapeutics, Inc. • Pharmaceutical preparations • New York

THIS CLINICAL TRIAL FUNDING AGREEMENT (this “Agreement”) is entered into as of February 25, 2011 (the “Effective Date”) between NILE THERAPEUTICS, INC., a Delaware company with offices at 4 West 4th Avenue, Suite 400, San Mateo, California 99402 (“Nile”) and MEDTRONIC, INC., a Minnesota corporation with offices at 710 Medtronic Parkway, Minneapolis, Minnesota 55432, U.S.A. (“Medtronic”) (each a “Party,” collectively the “Parties”).

AutoNDA by SimpleDocs
Contract
Clinical Trial Funding Agreement • May 5th, 2020 • New York

EX-10.1 2 v222336_ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 CLINICAL TRIAL FUNDING AGREEMENT THIS CLINICAL TRIAL FUNDING AGREEMENT (this “Agreement”) is entered into as of February 25, 2011 (the “Effective Date”) between NILE THERAPEUTICS, INC., a Delaware company with offices at 4 West 4th Avenue, Suite 400, San Mateo, California 99402 (“Nile”) and MEDTRONIC, INC., a Minnesota corporation with offices at 710 Medtronic Parkway, Minneapolis, Minnesota 55432, U.S.A. (“Medtronic”) (each a “Party,” collectively the “Parties”). RECITALS WHEREAS, Nile is a company focused on the use of hybrid natriuretic peptides, including but not limited to CD-NP, as defined in the Nile Patents (“Drug”, as further defined in Section 1.1.6 below); WHEREAS, Medtronic is a leader in the business of designing, manufacturing and marketing medical devices, including medical devices for delivery of various peptides such as the Pumps and Sets (as defined in Section 2.1 below) (collectively, the “Devices”, as further de

CLINICAL TRIAL FUNDING AGREEMENT
Clinical Trial Funding Agreement • October 23rd, 2024 • Lumos Pharma, Inc. • Pharmaceutical preparations • Delaware

This Clinical Trial Funding Agreement (this “Agreement”) is made as of October 22, 2024 (the “Effective Date”) by and between Double Point Ventures LLC, a Delaware limited liability company (“Lender”) and Lumos Pharma, Inc., a Delaware corporation (“Borrower”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!